7QBF

TC:CD320 in complex with nanobody TC-Nb34

7QBF の概要

• エントリーDOI: 10.2210/pdb7qbf/pdb
• 分子名称: Transcobalamin-2, CD320 antigen, Anti-transcobalamin-2 nanobody TC-Nb34, ... (8 entities in total)
• 機能のキーワード: transcobalamin, tc2, cd320, tcblr, b12, nanobody, transport protein
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 3
• 化学式量合計: 81334.10

構造登録者

Bloch, J.S.,Locher, K.P. (登録日: 2021-11-19, 公開日: 2022-03-16, 最終更新日: 2024-01-31)

主引用文献

Bloch, J.S.,Sequeira, J.M.,Ramirez, A.S.,Quadros, E.V.,Locher, K.P.
Generation of nanobodies targeting the human, transcobalamin-mediated vitamin B 12 uptake route.
Faseb J., 36:e22222-e22222, 2022

PubMed Abstract: Cellular uptake of vitamin B in humans is mediated by the endocytosis of the B carrier protein transcobalamin (TC) via its cognate cell surface receptor TCblR, encoded by the CD320 gene. Because CD320 expression is associated with the cell cycle and upregulated in highly proliferating cells including cancer cells, this uptake route is a potential target for cancer therapy. We developed and characterized four camelid nanobodies that bind holo-TC (TC in complex with B ) or the interface of the human holo-TC:TCblR complex with nanomolar affinities. We determined X-ray crystal structures of these nanobodies bound to holo-TC:TCblR, which enabled us to map their binding epitopes. When conjugated to the model toxin saporin, three of our nanobodies caused growth inhibition of HEK293T cells and therefore have the potential to inhibit the growth of human cancer cells. We visualized the cellular binding and endocytic uptake of the most potent nanobody (TC-Nb4) using fluorescent light microscopy. The co-crystal structure of holo-TC:TCblR with another nanobody (TC-Nb34) revealed novel features of the interface of TC and the LDLR-A1 domain of TCblR, rationalizing the decrease in the affinity of TC-B binding caused by the Δ88 mutation in CD320.

PubMed: 35218573
DOI: 10.1096/fj.202101376RR

実験手法

X-RAY DIFFRACTION (1.85 Å)